Abstract
Reductive late-stage functionalization of gibberellic acid is reported using three fluoroarylborane Lewis acids; (B(C6F5)3, B(3,5-C6H3(CF3)2), and B(2,4,6-C6H2F3)3) in combination with a tertiary silane and a borane (HBCat) reductant. In each case, C–O bond activation occurs, and different products are obtained depending on the reductant and catalyst employed.
Keywords: Late stage functionalization, Gibberellic acid, Selective deoxygenation, Hydrosilylative deoxygenation, Fluoroarylborane
Graphical Abstract

1. Introduction
Late stage functionalization (LSF) of natural products is a useful medicinal chemistry tool, but is challenging to execute as it requires a synthetic method able to chemo- and site-selectively manipulate complex structures, which, by their nature, usually contain a diverse array of off-target reactive groups.[1,2] Figure 1 demonstrates the LSF principle for the site-selective deoxygenation of erythromycin A, enabled either by a selectively-defining O-thiocarbonylation or -phosphitylation with a peptide catalyst (Fig. 1(a)).[3,4] Metal catalysts for deoxygenation are also feasible as recently demonstrated for the ruthenium-catalyzed primary alcohol reduction of cholic alcohol (Fig. 1(b)).[5] A similar preference for primary deoxygenation (silane reductant) was demonstrated using the main group Lewis acid B(C6F5)3 on a diosgenin derivative (Fig. 1(c)).[6] B(C6F5)3-catalyzed hydrosilylative deoxygenations have additionally been used to chemo-selectively reduce the hemiacetal of dihydroartemisinin or to open the lactone ring of gibberellic acid with an accompanying allylic transposition (Fig. 1(c)).[7]
Figure 1.
Selective deoxygenation of natural products.
Although the commercially available B(C6F5)3 has been the workhorse catalyst, fluorinated arylboranes have also been investigated for the reduction of diverse functional groups, with one form typically exhibiting superior reactivity to the others.[8–10] Our group recently discovered that tuning the position of fluorination led to catalysts for site-selective deoxygenation that yielded divergent products from a set of common cellulosic starting materials.[11] Site-selective modifications in complex natural products such as natamycin have also been reported using various fluoroaryl borane catalysts and silanes as reductants.[7] The choice of reductant (e.g. borane versus silane) can also alter which product is formed, as seen with carbohydrates under B(C6F5)3-catalyzed conditions.[12] These results led us to ask how modifications to the fluoroaryl borane catalyst and the reductant influences the selectivity for the deoxygenation of a multi-functional test molecule such as gibberellic acid.[13] Trialkylsilanes (Me2EtSiH or Et3SiH) and catecholborane (HBCat) were selected as the reductants while the following three fluoroarylboranes were chosen based on their differing Lewis acidity and steric profiles: B(C6F5)3, B((3,5-CF3)2C6H3)3 (BAr3,5-CF3), and B(2,4,6-F3C6H2)3 (BAr2,4,6-F).
2. Results and Discussion
As previously computed by Heiden, the three fluoroaryl borane Lewis acids in this study have hydride affinities (kcal/mol) that decrease from B(C6F5)3 to BAr3,5-CF3 to BAr2,4,6-F (Fig. 2(a)).[14] These hydricity values correspond to the negative free energy of hydride formation from the Lewis acid and H–. For the current study, we additionally computed electrostatic potential surfaces to compare both the Lewis acid and conjugate hydride forms; more negative regions of electron distribution are visualized by red (Fig. 2(b)). Not surprisingly, the borohydrides are overall more negative than the neutral boranes. Unexpected, however, was the difference between BAr3,5-CF3 and BAr2,4,6-F which have a similar hydride affinity. The computed surfaces indicate that the boron center in BAr3,5-CF3 is the most electron deficient of the three (most blue) while the hydride derived from BAr2,4,6-F is the most negatively charged of all three (most red). We conclude from these data that hydride affinity (a difference) might not provide the full story of the reactivity of the Lewis acids and their conjugate hydrides since it is possible that one form might play a more important role in a given transformation.
Figure 2.
Calculated hydride affinity (Heiden) and electrostatic surfaces of the tested fluoroaryl boranes
In the study comparing the three catalysts for the site-selective deoxygenation of cellulose-derived carbohydrates, the most significant differences were noted between B(C6F5)3 and BAr3,5-CF3.[11] For multiple carbohydrate starting materials the two catalysts favored different products. Although no definitive reasons were apparent, it was noted that the boron resting state for B(C6F5)3-catalyzed reactions was B(C6F5)3−H– while in the latter, it was the Lewis acid form. The higher nucleophilicity of BAr3,5-CF3−H− presumably promoted its consumption. In this study BAr2,4,6-F was typically a less reactive version of B(C6F5)3.[15]
The previously reported B(C6F5)3-catalyzed hydrosilylative deoxygenation of free gibberellic acid afforded the tetrasilyl-protected diester Si-1 in 93% yield via a cascade of dehydrosilylation, and reductive olefin migration/ lactone opening (Scheme 1(a)).[7] To enhance the starting material solubility and to avoid vigorous hydrogen evolution, the allylic alcohols of gibberellic acid were pre-silylated (Me2EtSi-, Et3Si-; Si-Gibb), and tested under ambient reaction conditions with excess Et3SiH. Unlike the results obtained with Gibb (Scheme 1(a)), Si-Gibb provided 1 (83%) along with the conjugated diene 2 (16%) (Scheme 1(b)).[16] Although it is unclear why pre-silylated Si-Gibb promotes elimination to 2, all B(C6F5)3-catalyzed deoxygenations favor product 1 as the major species.
Scheme 1.
Hydrosilylative deoxygenation of Gibb and Si-Gibb.
Since free gibberellic acid and silyl protected gibberellic acid react slightly differently, both forms were tested with the alternative reductant, catecholborane (HBCat). Interestingly, different products, 1 or 3, were obtained from Si-Gibb and Gibb after hydrolysis (Scheme 2). As evidenced from gas evolution on mixing either Gibb or Si-Gibb with HBCat (no catalyst necessary), the free alcohols and carboxylic acids were borylated, making the resulting borylated compounds the actual starting materials. Under these conditions isomerization to known 3 occurs in contrast to Si-Gibb, which converts to 1 (Scheme 2). In situ monitoring of the reactions by 19F and 11B NMR spectroscopy reveal that the fluoroarylborane catalyst rests as (C6F5)3B–H– in the reaction using Si-Gibb whereas it rests as various B(C6F5)3 Lewis adducts in reactions using Gibb. These observations agree with our previous DFT study on the silyl/boryl oxonium ions that can be formed from 2-propanol.[12] These calculations showed that a diboryl oxonium is significantly higher in energy than a mixed silyl-boryl or disilyl oxonium ion. In other words, boryl protected ethers are insufficiently Lewis basic to support the formation of a putative [diboryl oxonium][(C6F5)3B–H–] Lewis pair. In this situation a Lewis acid catalyzed allylic transposition becomes competitive over heterolytic cleavage of HBCat. Thus, the formation of 1 through C–O bond activation/cleavage predominates when relatively more basic silyl ethers are present under B(C6F5)3-catalyzed conditions, while non-reductive pathways dominate when the less basic boryl ester intermediates are involved.
Scheme 2.
Deoxygenation with HBCat as reductant.
Next, the less Lewis acidic fluoroarylboranes, BAr2,4,6-F and BAr3,5-CF3, were tested with Si-Gibb and silane reductants. Although B(C6F5)3 generates a mixture of 1 and 2, each compound can be prepared as the sole product by changing the catalyst (Scheme 3(a)). With 10 mol% BAr2,4,6-F, Me2EtSi-protected gibberellic acid was fully converted to 1 and isolated in a good yield (82%). Even though the yield was a little lower than that obtained with B(C6F5)3 and Gibb, 2 was not detectable by in situ 13C{1H} NMR. In contrast, using 10 mol% of BAr3,5-CF3 resulted in allylic alcohol reduction coupled with lactone opening and elimination. In situ 13C{1H} NMR monitoring indicated a lack of detectable intermediates, with Si-Gibb being smoothly converted to 2.[17]
Scheme 3.
Divergent deoxygenation with fluoroarylboranes.
We next sought to synthesize 2 from conjugated diene 4 via selective allylic alcohol reduction using a fluoroarylborane catalyst and silane (Scheme 3(b)). Silyl protected diene 4 was prepared via a previously reported procedure in 64% yield from gibberellic acid.[13] Under B(C6F5)3-catalyzed hydrosilylative deoxygenation conditions, 32% of reduced allylic alcohol 2 was obtained after 24 h, with only trace amounts of 2 being formed when BAr3,5-CF3 was the catalyst. Few examples of hydrosilylative allylic alcohol reductions with fluoroarylborane catalysts are known although several examples of C–O reductions on cyclic ethers have been reported.[18,19]
Unlike B(C6F5)3 catalyzed reactions, in situ spectroscopic studies of the BAr2,4,6-F and BAr3,5-CF3 reactions provided no clear evidence for how the borane speciated. In an attempt to observe a difference in the behavior of the catalysts an additional 20 mol% of an external Lewis base (PPh3) was added, which can promote the heterolysis of the silane into a borohydride/silylphosphonium ion pair.[20] In the case of BAr2,4,6-F the rate of forming 1 and 3 slowed and resonances for H–BAr2,4,6-F– were observed in the 19F NMR (−100.2 ppm for o-F, and −120.1 ppm for p-F) along with its cation Me2EtSi-PPh3+ (−3.29 ppm) by 31P NMR.[20,21] By contrast, addition of 20 mol% PPh3 to the BAr3,5-CF3 catalyzed reaction completely shut down its reduction to 2, and instead provided only partial conversion of Si-Gibb to 3. As discussed in Figure 1, despite having a similar net hydride affinity, both the borohydrides and borane Lewis acids have different electrostatic potential surfaces. In addition to these electrostatic differences, the lack of ortho-F groups in BAr3,5-CF3 makes it more sterically accessible to both the hydride source (Piers mechanism) and other competing Lewis bases.[9,22–24] The balance of these forces is especially complex in a multi-functional structure like gibberellic acid and so the diverging reactivity patterns is difficult to pin down to a specific feature of the catalysts.
3. Conclusion
Selective activation and cleavage of C–O bonds in gibberellic acid has been achieved employing different fluoroarylborane Lewis acid catalysts. Although the precise mechanistic reasons for the diverging behavior could not be unambiguously disentangled, a number of differences were noted, including changes in the electrostatic surfaces of the borane Lewis acid and their conjugate hydrides. Experimental studies noted that B(C6F5)3, which has the highest hydride affinity, rests as the borohydride. The partially fluorinated catalysts have lower hydride affinities and neither build up significant quantities of borohydride during catalysis. However, when PPh3 is added to a reaction the BAr2,4,6-F catalyst converts to the borohydride in situ while BAr3,5-CF3 does not. It is tempting to ascribe the difference in reaction selectivities to the propensity of the catalysts to form borohydride versus borane resting states, however, it is still too early to tell if this is the ultimate source of the divergent behavior.
4. Experimental section
4.1. General information
All reactions were performed at ambient temperature (25 °C, RT) unless otherwise specified. All workup procedures were performed under air with reagent grade reagents unless otherwise specified. Column chromatography was performed using SilaFlash P60 40–63 µm (230–400 mesh). Thin layer chromatography (TLC) was performed on SiliCycle Silica Gel 60 F254 plates and was visualized with ceric ammonium molybdate (CAM) stain. All NMR spectra were recorded on a Bruker Avance 600 MHz spectrometer at standard temperature and pressure. All deuterated solvents were used as received from Cambridge Isotope Laboratories, Inc. The residual solvent protons (1H) or the solvent carbons (13C) were used as internal standards. The following abbreviations are used in reporting NMR data: s, singlet; d, doublet; dd, doublet of doublets; dt, doublet of triplets; td, triplet of doublets; ddd, doublet of doublet of doublets; and m, multiplet. Where necessary, 2D COSY, and HSQC data were used for peak assignment. High Resolution Mass spectra were obtained on Q Exactive™ HF-X Hybrid Quadrupole-Orbitrap™ Mass spectrometer.
All chemicals were used as received, or otherwise described on how it was treated before use. Me2EtSiH and Et3SiH were purchased from Gelest, and degassed via three freeze-pump-thaw cycles and stored over molecular sieves in the glovebox. Catecholborane was purchased from Sigma-Aldrich, distilled prior to use, taken into a nitrogen filled glovebox, and stored at −48 °C. B(C6F5)3 was purchased from Strem and used as received. BAr2,4,6-F and BAr3,5-CF3 were synthesized via known methods.[10,24]
4.2. B(C6F5)3 catalyzed reaction with Si-Gibb and silane
In a N2-filled glove box, B(C6F5)3 (4.9 mg, 0.010 mmol, 0.10 equiv) was placed in a 1 dram vial and dissolved in 0.2 mL of CH2Cl2. To the catalyst solution was added Me2EtSiH (32 μL, 0.241 mmol, 2.50 equiv) and mixed. In a separate vial, Me2EtSi-Gibb (50 mg, 0.096 mmol, 1.00 equiv) was diluted with 0.3 mL of CH2Cl2. The catalyst and borane mixture was then added to the substrate solution in one portion. The reaction mixture was transferred to an NMR tube and sealed with a septum cap. After 24 h, the mixture was transferred to a vial and rinsed three times with 0.5 mL of MeOH. After concentrating the resulting solution in vacuo, the crude residue was purified by silica gel chromatography (30:1 CH2Cl2/MeOH to 20:1 to 10:1 to 5:1) to yield 1 (83%, 28 mg) and 2 (16%, 5.0 mg).
Compound 1: 1H NMR (600 MHz, Acetone-d6) δ 5.19 (br s, 1H), 5.06 (br s, 1H), 4.90 (br s, 1H), 4.04 (dd, J = 4.3, 2.0 Hz, 1H), 3.17 (d, J = 5.5 Hz, 1H), 3.16 – 3.12 (m, 1H), 2.77 (dt, J = 18.2, 3.5 Hz, 1H), 2.68 (dt, J = 16.3, 3.0 Hz, 1H), 2.49 (br s, 1H), 2.28 – 2.23 (m, 1H), 2.13 (m, 1H), 1.96 – 1.88 (m, 1H), 1.74 (dd, J = 11.0, 2.9 Hz, 1H), 1.69 – 1.58 (m, 2H), 1.49 – 1.39 (m, 2H), 1.32 (s, 3H); 13C NMR (151 MHz, Acetone-d6) δ 177.5, 176.2, 156.6, 142.1, 111.0, 105.7, 79.3, 70.5, 50.5, 50.0, 49.8, 49.7, 48.8, 47.2, 46.6, 40.1, 38.8, 33.4, 22.2, 19.4. HRMS (EI) calculated for C19H24O6Na [M+Na]+:371.1465; found 371.1459.
Compound 2: 1H NMR (600 MHz, Methanol-d4) δ 5.85 (d, J = 9.8 Hz, 1H), 5.51 (d, J = 9.8 Hz, 1H), 5.10 (t, J = 2.5 Hz, 1H), 3.15 – 3.01 (m, 1H), 2.98 – 2.81 (m, 2H), 2.75 – 2.64 (m, 1H), 2.60 – 2.42 (m, 2H), 2.31 – 2.12 (m, 1H), 2.06 (dd, J = 10.1, 2.6 Hz, 1H), 2.03 – 1.89 (m, 1H), 1.73 (td, J = 11.9, 6.4 Hz, 1H), 1.64 (ddd, J = 10.7, 7.0, 2.6 Hz, 1H), 1.59 (dd, J = 10.1, 2.5 Hz, 1H), 1.21 (s, 3H); 13C NMR (151 MHz, Methanol-d4) δ 178.2, 177.8, 156.0, 136.5, 132.4, 128.9, 127.8, 105.8, 80.0, 57.1, 55.9, 53.9, 52.4, 40.6, 40.5, 26.1, 24.5, 21.6. HRMS (EI) calculated for C19H22O5Na [M+Na]+: 353.1360; found: 353.1370.
4.3. B(C6F5)3 catalyzed reaction with HBCat
In a N2-filled glove box, B(C6F5)3 (3.6 mg, 0.007 mmol, 0.10 equiv) was placed in a 1 dram vial and dissolved in 0.2 mL of CH2Cl2. To the catalyst solution was added HBCat (37 μL, 0.350 mmol, 5.00 equiv) and mixed. In a separate vial, Me2EtSi-Gibb (36 mg, 0.070 mmol, 1.00 equiv) was diluted with 0.3 mL of CH2Cl2. The catalyst and borane mixture was then added to the substrate solution in one portion. The reaction mixture was transferred to an NMR tube and sealed with a septum cap. After 24 h, the mixture was transferred to a vial and rinsed three times with 0.5 mL of MeOH. After concentrating the resulting solution in vacuo, the crude residue was purified by silica gel chromatography (100% CH2Cl2 to 30:1 CH2Cl2/MeOH to 20:1 to 10:1 to 5:1) to yield 1 as a clear film in 90% yield (22.0 mg, average over two runs).
4.4. Selective deoxygenation with BAr2,4,6-F
In a N2-filled glove box, BAr2,4,6-F (3.2 mg, 0.008 mmol, 0.10 equiv) was placed in a 1 dram vial and dissolved in 0.2 mL of CH2Cl2. To the catalyst solution was added Me2EtSiH (38 μL, 0.308 mmol, 4.00 equiv) and mixed. In a separate vial, Me2EtSi-Gibb (40 mg, 0.077 mmol, 1.00 equiv) was diluted with 0.3 mL of CH2Cl2. The catalyst and silane mixture was then added to the substrate solution in one portion. The reaction mixture was transferred to an NMR tube and sealed with a septum cap. After 24 h, the mixture was transferred to a vial and rinsed three times with 0.5 mL of MeOH. After concentrating the resulting solution in vacuo, the crude residue was purified by silica gel chromatography (20:1 CH2Cl2/MeOH to 10:1 to 8:1 to 5:1) to yield 1 as a clear film in 82% yield (22.0 mg).
4.5. Selective deoxygenation with BAr3,5-CF3
In a N2-filled glove box, BAr3,5-CF3 (4.5 mg, 0.007 mmol, 0.10 equiv) was placed in a 1 dram vial and dissolved in 0.2 mL of CH2Cl2. To the catalyst solution, was added Et3SiH (28 μL, 0.174 mmol, 2.50 equiv) and mixed. In a separate vial, Et3Si-Gibb (40 mg, 0.070 mmol, 1.00 equiv) was diluted with 0.3 mL of CH2Cl2. The catalyst and silane mixture was then added to the substrate solution in one portion. The reaction mixture was transferred to NMR tube and sealed with a septum cap. After 24 h, the mixture was transferred to a vial and rinsed three times with 0.5 mL of MeOH. After concentrating the resulting solution in vacuo, the crude residue was purified by silica gel chromatography (20:1 CH2Cl2/MeOH to 10:1 to 8:1 to 5:1) to yield 2 as a clear film in 51% yield (15.7 mg, average over 3 runs).
Supplementary Material
Gibberellic acid derivatives are synthesized with fluoroarylborane catalysts.
An example of selective deoxygenation in a natural product
Selective deoxygenation is possible with silane and borane reductants.
Acknowledgments
This work was exclusively supported by the National Institute of General Medicine (5R01 GM130693). We thank UNC’s Department of Chemistry Mass Spectrometry Core Laboratory, especially Dr. Brandie Ehrmann for her assistance with the mass spectrometry analysis.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Declaration of interests
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://doi.org/
References and notes
- [1].Shugrue CR, Miller SJ, Applications of Nonenzymatic Catalysts to the Alteration of Natural Products, Chem. Rev 117 (2017) 11894–11951. doi: 10.1021/acs.chemrev.7b00022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Cernak T, Dykstra KD, Tyagarajan S, Vachal P, Krska SW, The medicinal chemist’s toolbox for late stage functionalization of drug-like molecules, Chem. Soc. Rev 45 (2016) 546–576. doi: 10.1039/c5cs00628g. [DOI] [PubMed] [Google Scholar]
- [3].Jordan PA, Miller SJ, An approach to the site-selective deoxygenation of hydroxy groups based on catalytic phosphoramidite transfer, Angew. Chemie - Int. Ed 51 (2012) 2907–2911. doi: 10.1002/anie.201109033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Yoganathan S, Miller SJ, Structure diversification of vancomycin through peptide-catalyzed, site-selective lipidation: A catalysis-based approach to combat glycopeptide-resistant pathogens, J. Med. Chem 58 (2015) 2367–2377. doi: 10.1021/jm501872s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Dai X-J, Li C-J, En Route to a Practical Primary Alcohol Deoxygenation, J. Am. Chem. Soc 138 (2016) 5433–5440. doi: 10.1021/jacs.6b02344. [DOI] [PubMed] [Google Scholar]
- [6].Denancé M, Guyot M, Samadi M, Short synthesis of 16β-hydroxy-5α-cholestane-3,6-dione a novel cytotoxic marine oxysterol, Steroids, 71 (2006) 599–602.doi: 10.1016/j.steroids.2006.03.002. [DOI] [PubMed] [Google Scholar]
- [7].Bender TA, Payne PR, Gagné MR, Late-stage chemoselective Functional-Group manipulation of bioactive natural products with super-electrophilic silylium ions, Nat. Chem 10 (2018) 85–90. doi: 10.1038/NCHEM.2863. [DOI] [PubMed] [Google Scholar]
- [8].Hamasaka G, Tsuji H, Uozumi Y, Organoborane-Catalyzed Hydrogenation of Unactivated Aldehydes with a Hantzsch Ester as a Synthetic NAD(P)H Analogue, Synlett. 26 (2015) 2037–2041. doi: 10.1055/s-0034-1378846. [DOI] [Google Scholar]
- [9].Yin Q, Kemper S, Klare HFT, Oestreich M, Boron Lewis Acid-Catalyzed Hydroboration of Alkenes with Pinacolborane: BArF3Does What B(C6F5)3 Cannot Do!, Chem. - A Eur. J 22 (2016) 13840–13844. doi: 10.1002/chem.201603466. [DOI] [PubMed] [Google Scholar]
- [10].Lawson JR, Wilkins LC, Melen RL, Tris(2,4,6-trifluorophenyl)borane: An Efficient Hydroboration Catalyst, Chem. - A Eur. J 23 (2017) 10997–11000. doi: 10.1002/chem.201703109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Seo Y, Lowe JM, Gagné MR, Controlling Sugar Deoxygenation Products from Biomass by Choice of Fluoroarylborane Catalyst, ACS Catal. 9 (2019) 6648–6652. doi: 10.1021/acscatal.9b01578. [DOI] [Google Scholar]
- [12].Lowe JM, Seo Y, Gagné MR, Boron-Catalyzed Site-Selective Reduction of Carbohydrate Derivatives with Catecholborane, ACS Catal. 8 (2018) 8192–8198. doi: 10.1021/acscatal.8b02337. [DOI] [Google Scholar]
- [13].Huigens RW III, Morrison KC, Hicklin RW, Flood TA Jr, Richter MF, Hergenrother PJ, A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products, Nat. Chem 5 (2013) 195–202. doi: 10.1038/nchem.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Heiden ZM, Lathem AP, Establishing the hydride donor abilities of main group hydrides, Organometallics. 34 (2015) 1818–1827. doi: 10.1021/om5011512. [DOI] [Google Scholar]
- [15].Sivaev IB, Bregadze VI, Lewis acidity of boron compounds, Coord. Chem. Rev 270–271 (2014) 75–88. doi: 10.1016/j.ccr.2013.10.017. [DOI] [Google Scholar]
- [16]. Testing this reaction on the bench top under non-anhydrous conditions gave similar results but required and extra 2 equiv. of silane to “dry” the solvent.
- [17]. Me2EtSi-Gibb with BAr3,5-CF3 and Me2EtSiH also gave the same product 3 as the major compound but accompanied with a small amount of 1 according to the in-situ 13C NMR analysis.
- [18].MacK DJ, Guo B, Njardarson JT, Synthesis of allylic and homoallylic alcohols from unsaturated cyclic ethers using a mild and selective C–O reduction approach, Chem. Commun 48 (2012) 7844–7846. doi: 10.1039/c2cc33551d. [DOI] [PubMed] [Google Scholar]
- [19].Bender TA, Dabrowski JA, Gagné MR, Delineating The Multiple Roles of B(C6F5)3 in the Chemoselective Deoxygenation of Unsaturated Polyols, ACS Catal. 6 (2016) 8399–8403. doi: 10.1021/acscatal.6b02551. [DOI] [Google Scholar]
- [20].Gudz A, Payne PR, Gagné MR, Phosphines as Silylium Ion Carriers for Controlled C–O Deoxygenation: Catalyst Speciation and Turnover Mechanisms, Organometallics. 36 (2017) 4047–4053. doi: 10.1021/acs.organomet.7b00689. [DOI] [Google Scholar]
- [21].Morozova V, Mayer P, Berionni G, Scope and Mechanisms of Frustrated Lewis Pair Catalyzed Hydrogenation Reactions of Electron-Deficient C=C Double Bonds, Angew. Chemie - Int. Ed 54 (2015) 14508–14512. doi: 10.1002/anie.201507298. [DOI] [PubMed] [Google Scholar]
- [22].Parks DJ, Blackwell JM, Piers WE, Studies on the mechanism of B(C6F5)3-catalyzed hydrosilation of carbonyl functions, J. Org. Chem 65 (2000) 3090–3098. doi: 10.1021/jo991828a. [DOI] [PubMed] [Google Scholar]
- [23].Yin Q, Soltani Y, Melen RL, Oestreich M, BArF3-Catalyzed Imine Hydroboration with Pinacolborane Not Requiring the Assistance of an Additional Lewis Base, Organometallics. 36 (2017) 2381–2384. doi: 10.1021/acs.organomet.7b00381. [DOI] [Google Scholar]
- [24].Herrington TJ, Thom AJW, White AJP, Ashley AE, Novel H2 activation by a tris[3,5-bis(trifluoromethyl)phenyl] borane frustrated Lewis pair, Dalt. Trans 41 (2012) 9019–9022. doi: 10.1039/c2dt30384a. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





